APA

Yang Z., Wang H., Salcedo T. W., Suchard S. J., Xie J. H., Schneeweis L. A., Fleener C. A., Calore J. D., Shi R., Zhang S. X. Y., Rodrigues A. D., Car B. D., Marathe P. H. & Nadler S. G. (20160209). Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699. : The Journal of pharmacology and experimental therapeutics.

Chicago

Yang Zheng, Wang Haiqing, Salcedo Theodora W, Suchard Suzanne J, Xie Jenny H, Schneeweis Lumelle A, Fleener Catherine A, Calore James D, Shi Rong, Zhang Sean X Y, Rodrigues A David, Car Bruce D, Marathe Punit H and Nadler Steven G. 20160209. Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699. : The Journal of pharmacology and experimental therapeutics.

Harvard

Yang Z., Wang H., Salcedo T. W., Suchard S. J., Xie J. H., Schneeweis L. A., Fleener C. A., Calore J. D., Shi R., Zhang S. X. Y., Rodrigues A. D., Car B. D., Marathe P. H. and Nadler S. G. (20160209). Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699. : The Journal of pharmacology and experimental therapeutics.

MLA

Yang Zheng, Wang Haiqing, Salcedo Theodora W, Suchard Suzanne J, Xie Jenny H, Schneeweis Lumelle A, Fleener Catherine A, Calore James D, Shi Rong, Zhang Sean X Y, Rodrigues A David, Car Bruce D, Marathe Punit H and Nadler Steven G. Integrated Pharmacokinetic/Pharmacodynamic Analysis for Determining the Minimal Anticipated Biological Effect Level of a Novel Anti-CD28 Receptor Antagonist BMS-931699. : The Journal of pharmacology and experimental therapeutics. 20160209.